No Data
No Data
ABVC BioPharma 3Q Rev $389,276 >ABVC3
Express News | ABVC Biopharma, Inc. Reports Q3 2024 Financial Results and Operational Milestones
ABVC BioPharma | 10-Q: Q3 2024 Earnings Report
ABVC BioPharma Receives $50,000 in Incremental Licensing Fees, Boosting Total Payments to $346,000 From Its Three Strategic Partners
12 Health Care Stocks Moving In Tuesday's After-Market Session
Express News | ABVC Biopharma- Got Written Notification From Nasdaq, Indicating Co Regained Compliance With Listing Rules 5635(a)(1) and 5635(a)(2)
No Data
No Data
周淮安 : What do you think will happen here?
Jaguar8 OP 周淮安 : No volume as of this time